Status:

COMPLETED

Less to Hold - A Comparison of Bladder Toxicities (Side Effects) in Patients Undergoing Prostate Radiotherapy Between Patients Treated With Empty Bladder and Those on a Drinking Protocol.

Lead Sponsor:

Lancashire Teaching Hospitals NHS Foundation Trust

Conditions:

Prostate Cancer

Radiotherapy Side Effect

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

Radical radiotherapy to the prostate is conventionally treated with a full bladder with the aim of minimising dose to the bladder and small bowel to prevent significant side effects. Tolerance of the ...

Detailed Description

50 patients receiving radical radiotherapy to the prostate were randomised using closed envelope technique 1:1 into 2 groups. Group A followed the conventional drinking protocol at our centre (200ml p...

Eligibility Criteria

Inclusion

  • Prostate cancer receiving radical radiotherapy.

Exclusion

  • Not nodal disease.
  • Not prostate bed radiotherapy.

Key Trial Info

Start Date :

March 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 25 2019

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03832803

Start Date

March 1 2017

End Date

January 25 2019

Last Update

February 6 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lancashire Teaching Hospitals NHS Foundation Trust

Preston, United Kingdom